Literature DB >> 23249343

Vector and helper genome rearrangements occur during production of helper-dependent adenoviral vectors.

Miwon Ahn1, Aisha Gamble, Scott R Witting, Jack Magrisso, Sneha Surendran, Silvana Obici, Núria Morral.   

Abstract

Helper-dependent adenoviral vectors (HD Ad) hold extreme promise for gene therapy of human diseases. All viral genes are deleted in HD Ad vectors, and therefore, the presence of a helper virus is required for their production. Current methods to minimize helper contamination in large-scale preparations rely on the use of the Cre/loxP system. The inclusion of loxP sites flanking the packaging signal results in its excision in the presence of Cre recombinase, preventing helper genome encapsidation. It is well established that the level of Cre recombinase activity is important in determining the degree of helper contamination. However, there is little information on other mechanisms that could also play an important role. We have generated several HD Ad vectors containing a rapalog-inducible system to regulate transgene expression, or LacZ under the control of the elongation factor 1 α promoter. Large-scale production of these vectors resulted in abundant helper contamination. Viral DNA analysis revealed the presence of rearrangements between vector and helper genomes. The rearrangements involved a helper DNA molecule with a fragment of the left arm of the HD Ad vector, including its ITR, packaging signal, and some stuffer sequence. Overall, our data suggest that helper DNA molecules that accumulate after Cre recombinase activity are prone to rearrangements, resulting in helper genomes that have incorporated a packaging signal from the vector. Helper particles with rearranged genomes have a growth advantage. This study identifies a novel mechanism leading to helper contamination during helper-dependent adenoviral vector production.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23249343      PMCID: PMC4015077          DOI: 10.1089/hgtb.2012.198

Source DB:  PubMed          Journal:  Hum Gene Ther Methods        ISSN: 1946-6536            Impact factor:   2.396


  45 in total

1.  Optimization of the helper-dependent adenovirus system for production and potency in vivo.

Authors:  V Sandig; R Youil; A J Bett; L L Franlin; M Oshima; D Maione; F Wang; M L Metzker; R Savino; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  Gene therapy: the first decade.

Authors:  A Mountain
Journal:  Trends Biotechnol       Date:  2000-03       Impact factor: 19.536

3.  Cre levels limit packaging signal excision efficiency in the Cre/loxP helper-dependent adenoviral vector system.

Authors:  Philip Ng; Carole Evelegh; Derek Cummings; Frank L Graham
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

4.  Optimization of the generation and propagation of gutless adenoviral vectors.

Authors:  Kiran Sakhuja; P Seshidhar Reddy; Shanthi Ganesh; Floro Cantaniag; Scott Pattison; Paullin Limbach; Dawn B Kayda; Michael J Kadan; Michael Kaleko; Sheila Connelly
Journal:  Hum Gene Ther       Date:  2003-02-10       Impact factor: 5.695

Review 5.  The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis.

Authors:  J D McGarry; N F Brown
Journal:  Eur J Biochem       Date:  1997-02-15

6.  A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging.

Authors:  R J Parks; F L Graham
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  A system for small-molecule control of conditionally replication-competent adenoviral vectors.

Authors:  Heung Chong; Anja Ruchatz; Tim Clackson; Victor M Rivera; Richard G Vile
Journal:  Mol Ther       Date:  2002-02       Impact factor: 11.454

8.  Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity.

Authors:  Dmitry M Shayakhmetov; Anuj Gaggar; Shaoheng Ni; Zong-Yi Li; André Lieber
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

9.  Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue.

Authors:  J Chen; X F Zheng; E J Brown; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

10.  Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5.

Authors:  Simon N Waddington; Alan L Parker; Menzo Havenga; Stuart A Nicklin; Suzanne M K Buckley; John H McVey; Andrew H Baker
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

View more
  5 in total

1.  Amelioration of carbon tetrachloride-induced cirrhosis and portal hypertension in rat using adenoviral gene transfer of Akt.

Authors:  Gang Deng; Xiang-Jun Huang; Hong-Wu Luo; Fei-Zhou Huang; Xun-Yang Liu; Yong-Heng Wang
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

2.  Canine helper-dependent vectors production: implications of Cre activity and co-infection on adenovirus propagation.

Authors:  Paulo Fernandes; Ana I Almeida; Eric J Kremer; Paula M Alves; Ana S Coroadinha
Journal:  Sci Rep       Date:  2015-03-16       Impact factor: 4.379

Review 3.  Progresses towards safe and efficient gene therapy vectors.

Authors:  Sergiu Chira; Carlo S Jackson; Iulian Oprea; Ferhat Ozturk; Michael S Pepper; Iulia Diaconu; Cornelia Braicu; Lajos-Zsolt Raduly; George A Calin; Ioana Berindan-Neagoe
Journal:  Oncotarget       Date:  2015-10-13

4.  Fiber-modified adenovirus-mediated suicide gene therapy can efficiently eliminate bladder cancer cells in vitro and in vivo.

Authors:  De-Gui Wang; Mei-Jun Zhao; Yong-Qiang Liu; Xiang-Wen Liu; Hai-Tao Niu; Yan-Feng Song; Ying-Xia Tian
Journal:  Oncotarget       Date:  2016-11-01

5.  Identification of Milk Fat Metabolism-Related Pathways of the Bovine Mammary Gland during Mid and Late Lactation and Functional Verification of the ACSL4 Gene.

Authors:  Yongliang Fan; Ziyin Han; Xubin Lu; Huimin Zhang; Abdelaziz Adam Idriss Arbab; Juan J Loor; Yi Yang; Zhangping Yang
Journal:  Genes (Basel)       Date:  2020-11-16       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.